Vivoryon Therapeutics AG(DE:05Y)
€0.71-0.03 (-3.77%)
DE:05Y
Vivoryon Therapeutics AG earnings date
€0.71
At close:-0.03 (-3.77%)
Vivoryon Therapeutics AG (05Y) Q2 2023 Earnings Report
40 Followers
DE:05Y Q2 2023 EPS Results
- Actual EPS
- -EUR 0.41
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.60
DE:05Y Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 09/07/2023
- Time
- Before Open
- Conference Call
- Thursday, September 7, 2023
DE:05Y Upcoming Earnings
Vivoryon Therapeutics AG's next earnings date is estimated for April 29, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:05Y Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 29, 2027 | 2026 (Q4) | ―- | -0.12 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―- | -0.21 | ― | |
| Aug 06, 2026 | 2026 (Q2) | ―-0.11 | -0.21 | 45.71% (+0.10) | |
| Jun 11, 2026 | 2026 (Q1) | ―- | -0.27 | ― | |
| Apr 23, 2026 | 2025 (Q4) | ―-0.12 | -0.27 | 56.13% (+0.15) | |
| Dec 04, 2025 | 2025 (Q3) | ―- | -0.52 | ― | |
| Sep 04, 2025 | 2025 (Q2) | ―-0.21 | -0.63 | 66.67% (+0.42) | |
| Jun 17, 2025 | 2025 (Q1) | ―- | -0.68 | ― | |
| Apr 29, 2025 | 2024 (Q4) | ―-0.27 | -0.68 | 60.21% (+0.41) | |
| Dec 10, 2024 | 2024 (Q3) | ―- | -0.41 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

